SPO11-4 Antibody

What is SPO11 and why is it important in meiotic research?

SPO11 is an evolutionary conserved topoisomerase-like protein that catalyzes programmed double-strand breaks (DSBs) essential for initiating meiotic recombination. It functions through a transesterase mechanism, forming covalent 5′-phosphotyrosyl linkages with DNA during break formation . SPO11 is crucial for proper chromosomal segregation during meiosis, with its dysfunction leading to meiotic arrest and infertility in various organisms. The protein forms specialized complexes with partners like TOP6BL in mammals, demonstrating species-specific variations in its dimerization potential and regulatory mechanisms .

What distinguishes SPO11-4 antibody from other SPO11 antibodies?

SPO11-4 antibody is specifically designed to recognize epitopes in the SPO11 protein that remain accessible when the protein is in complex with DNA or other protein partners. Unlike other SPO11 antibodies that may target regions involved in catalytic activity (such as the Y138 residue in mouse SPO11), SPO11-4 antibody targets epitopes that allow detection of both free and DNA-bound forms of SPO11 . This makes it particularly valuable for studying SPO11 in its active state during meiotic recombination.

What are the principal research applications for SPO11-4 antibody?

SPO11-4 antibody can be utilized across multiple experimental platforms:

• Immunodetection of SPO11-DNA covalent complexes via slot blot analysis

• Chromatin immunoprecipitation (ChIP) to identify SPO11-associated recombination hotspots

• Immunofluorescence microscopy for localizing SPO11 on meiotic chromosomes

• Western blotting for analyzing SPO11 expression and post-translational modifications

• Immunoprecipitation to study SPO11-containing protein complexes

How can SPO11-4 antibody be used to detect covalent SPO11-DNA complexes?

To detect covalent SPO11-DNA complexes:

• Perform DNA cleavage reactions with recombinant SPO11 or isolated meiotic chromatin

• Purify DNA-protein complexes using ultracentrifugation through a CsCl cushion (157,000 g for 17.5 hours at 24°C)

• Wash DNA pellets containing covalently bound proteins with 70% ethanol

• Dissolve pellets in TE buffer (10 mM Tris-HCl pH 8.0, 0.1 mM EDTA) for 2 hours at room temperature

• Mix samples with sodium phosphate buffer (pH 6.5) and apply to a nitrocellulose membrane

• Detect SPO11 using SPO11-4 antibody via immunoblotting

This approach enables direct visualization of the transesterase activity of SPO11 and confirmation of its covalent attachment to DNA.

What protocol should be followed for effective ChIP using SPO11-4 antibody?

For optimal ChIP results with SPO11-4 antibody:

• Crosslink protein-DNA complexes with 1% formaldehyde for 10-15 minutes at room temperature

• Extract DNA and fragment to approximately 200-500 bp

• Immunoprecipitate using SPO11-4 antibody (typically 2-5 μg per reaction)

• Perform multiplex PCR (mPCR) or quantitative real-time PCR (qPCR) with primers designed for regions of interest

• Include primers for known recombination hotspots (positive control) and cold regions (negative control)

This method allows precise mapping of SPO11-DNA interaction sites and quantification of SPO11 enrichment at specific genomic loci.

How should samples be prepared for immunoblotting with SPO11-4 antibody?

For optimal immunoblotting results:

• Prepare protein extracts in buffer containing protease inhibitors to prevent SPO11 degradation

• Separate proteins using SDS-PAGE

• Transfer to nitrocellulose membrane (0.45-μm pore size recommended)

• Block with appropriate blocking agent (5% non-fat milk or BSA)

• Incubate with SPO11-4 antibody (typically 1:1,000 dilution)

• Wash thoroughly and incubate with HRP-conjugated secondary antibody

• Develop using ECL detection reagent and image using a sensitive imaging system

For detection of SPO11-DNA complexes, consider using slot-blot methodology rather than traditional Western blotting to better preserve these delicate complexes.

What controls are essential when using SPO11-4 antibody in experimental protocols?

Critical controls include:

• Positive controls:

  • Testicular tissue known to express SPO11

  • Recombinant SPO11 protein (approximately 10 ng)

  • SPO11 wild-type samples for comparison with mutants

• Negative controls:

  • Catalytically inactive SPO11 mutants (e.g., SPO11-Y138F)

  • No-protein controls (DNA only and buffer only)

  • Tissues that do not express SPO11

• Experimental controls:

  • Input samples (pre-immunoprecipitation) for ChIP experiments

  • Secondary antibody-only controls to assess background

  • Competitive blocking with immunizing peptide when available

What are the optimal conditions for SPO11-4 antibody in immunoprecipitation experiments?

For effective immunoprecipitation:

• Use fresh cell or tissue lysates in non-denaturing buffer (typically containing 25 mM HEPES-NaOH pH 7.5, 1 mM DTT, 0.1 mg/ml BSA)

• Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Incubate lysates with SPO11-4 antibody (2-5 μg) overnight at 4°C with gentle rotation

• Add protein A/G beads and incubate for 2-4 hours at 4°C

• Wash extensively with buffer containing mild detergent (0.02% NP-40)

• Elute bound proteins and analyze by immunoblotting or mass spectrometry

For DNA co-immunoprecipitation experiments, modified protocols that preserve DNA-protein interactions should be employed .

How can the specificity of SPO11-4 antibody be validated?

To validate SPO11-4 antibody specificity:

• Compare wild-type samples with SPO11 knockout/knockdown samples

• Perform parallel experiments with multiple antibodies targeting different SPO11 epitopes

• Conduct peptide competition assays with the immunizing peptide

• Test reactivity against recombinant SPO11 protein and SPO11 mutants (e.g., SPO11-Y138F)

• Verify by mass spectrometry that immunoprecipitated protein is indeed SPO11

• Examine cross-reactivity with related proteins from the topoisomerase family

What are common issues when using SPO11-4 antibody and how can they be resolved?

How can signal-to-noise ratio be improved when using SPO11-4 antibody?

To improve signal-to-noise ratio:

• Optimize antibody concentration through titration experiments (typically 1:500 to 1:2000 for immunoblotting)

• Increase washing stringency with higher salt concentrations

• Use longer incubation times with gentler agitation

• Pre-absorb antibody with proteins from non-relevant tissues

• Consider using monoclonal antibodies if polyclonal shows high background

• For immunofluorescence, use antigen retrieval methods to enhance signal

• For ChIP, increase the specificity of DNA amplification with carefully designed primers

What factors affect SPO11-4 antibody performance in different experimental contexts?

Several factors impact antibody performance:

• Sample preparation:

  • Fixation method can affect epitope accessibility (formaldehyde crosslinking may mask certain epitopes)

  • Presence of detergents (NP-40, Sarkosyl) influences protein-protein interactions

  • Buffer composition affects SPO11 conformation and complex stability

• Experimental conditions:

  • Temperature and time of incubation influence antibody binding kinetics

  • Presence of divalent cations (Mn²⁺, Mg²⁺) may affect SPO11 conformation and activity

  • DNA binding can induce conformational changes in SPO11, potentially affecting epitope accessibility

• Technical factors:

  • Fresh vs. frozen samples impact protein integrity

  • Antibody storage conditions affect binding affinity

  • Detection method sensitivity influences minimum detectable SPO11 levels

How can SPO11-4 antibody be used to investigate SPO11 dimerization mechanisms?

To study SPO11 dimerization:

• Perform size exclusion chromatography followed by immunoblotting with SPO11-4 antibody to distinguish monomeric and dimeric forms

• Use chemical crosslinking to stabilize transient dimers before immunoprecipitation

• Employ SPO11-4 antibody in proximity ligation assays to visualize closely associated SPO11 molecules

• Compare wild-type SPO11 with dimerization-deficient mutants

• Study the effects of ATP and DNA binding on dimerization status

Research indicates mouse SPO11 forms monomeric complexes with TOP6BL (110.3 kDa) and exhibits weak dimerization potential, unlike topoisomerase VI which forms stable dimers .

How can SPO11-4 antibody be used to analyze SPO11's conformational changes upon DNA binding?

To investigate conformational changes:

• Compare crosslinking patterns of SPO11 in the presence and absence of DNA

• Use SPO11-4 antibody to immunoprecipitate SPO11 under different conditions (with/without DNA)

• Employ negative-stain electron microscopy (nsEM) with immunogold labeling to visualize structural changes

• Analyze crosslinking spectra across the entire SPO11 complex with and without DNA

• Compare results from wild-type SPO11 with catalytically inactive mutants (SPO11-Y138F)

Evidence suggests SPO11 adopts a more closed configuration upon DNA binding, with significant changes in crosslinking patterns throughout the complex .